Inrom has agreed to buy the controlling stake of Alumlight Production through its subsidiary, Ytong Ltd. for approximately NIS 192.5 million. The acquisition marks another significant step in the implementation of the Inrom Group’s strategic plan to deepen and expand its activities in the construction markets. Inrom Construction Industries Ltd. One of the largest and […]
Author: Idan Nishlis
Delinea, a leading provider of privileged access management, has completed the acquisition of the Israeli start-up Authomize Ltd. Authomize has developed a cloud identity and access security platform that detects and eliminates identity-based threats throughout the cloud. Herzog advised the buyer in the transaction, led by Michal Herzfeld, and including Yahya Qaq; Dr. Yuval Navot, Ronen Avner, Efrat Kesler […]
Ambitious cyber company Snyk has acquired the Israeli cyber start-up Helios in a cash-stock deal estimated at tens of millions of USD. EBN advised Amiti Ventures, a leading deep tech seed-stage VC firm in Israel, in relation to the sale of its portfolio company Helios. Following the purchase, Synk’s security products will cover the entire […]
Taro Pharmaceutical Industries has signed a merger agreement with its controlling shareholder, Sun Pharma, reflecting an equity value for Taro of USD 1.6 billion. Skadden, as U.S. counsel with Goldfarb Gross Seligman, as Israeli counsel, represented the Special Committee of the Board of Directors of Taro, which evaluated the proposal together with an independent financial […]
Many Israeli unicorns, startups valued at a billion dollars or more, did not survive the flock of black swans that hit the local tech ecosystem over the past couple of years. There are those who are entering 2024 in a much stronger position. Read this insightful report on the state of play in Calcalist: https://www.calcalistech.com/ctechnews/article/skicmwh006 […]
Biopharmaceutical company, NurExone Biologic Inc. has completed a private placement of CAD2 million. The Toronto-listed company develops a platform for biologically-guided ExoTherapy using exosomes as a next generation drug delivery system. This placement is further testament to the resilience of the Israeli life sciences sector. Gowling WLG advised NurExone Biologic on closing this transaction.
FIMI Opportunity Funds has sold a 50.2% stake in G1 Security Solutions to Universal Motors Israel (UMI) for NIS 200 million. This marks the third significant deal for FIMI in the last two weeks, following the recently announced sale of up to 20% of the share capital of Amal Holdings to Poalim Equity and the […]
Clal Insurance Group, one of the leading insurance and long term savings companies in Israel, has set up a joint venture with Mediterranean Towers for the establishment, operation and management of assisted living facilities in Israel through the formation of special purpose limited partnerships. The total investment in the joint venture will be NIS500 million, […]
Managed out of Kfar Aza, southern Israel, the Kafrit Group has bought the entire holdings of Absa Resin Technologies Inc., a Canadian company specializing in the production and sale of mixtures for the plastics industry using recycled material. Shibolet advised the Kafrit Group is a worldwide leader engaged in production and marketing of concentrates and mixtures […]
Pomvom, an Israeli company, which develops experiential content to amusement parks and attractions globally, is merging with the SPAC, Israel Acquisitions Corp, which was set up by Izhar Shay last year. Goldfarb, Gross, Seligman advised Pomvom, with the team comprising Amir Tzafrir, Aaron M. Lampert, Gur Nabel, Yaron Sever, Revital Shprung-Levy, Shuki Gottlieb and Esther Tayar. Eyal Peled, partner in Greenberg Traurig’s […]
